Pharmaceuticals

Global Chronic Idiopathic Constipation (CIC) Drugs Market Insights, Forecast to 2025

  • QYR2792349
  • 116 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.

In 2017, the global Chronic Idiopathic Constipation (CIC) Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Chronic Idiopathic Constipation (CIC) Drugs market based on company, product type, application and key regions.

This report studies the global market size of Chronic Idiopathic Constipation (CIC) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Idiopathic Constipation (CIC) Drugs in these regions.

This research report categorizes the global Chronic Idiopathic Constipation (CIC) Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Chronic Idiopathic Constipation (CIC) Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Chronic Idiopathic Constipation (CIC) Drugs include

Actavis

Chugai Pharmaceutical

Ferring International Center

Synergy Pharmaceuticals

Pfizer

GlaxoSmithKline

Roche Holding

Sanofi

Bayer

Salix Pharmaceuticals

Sucampo Pharmaceuticals

Ironwood Pharmaceuticals

Progenics Pharmaceuticals

Market Size Split by Type

Lubiprostone

Linaclotide

Others

Market Size Split by Application

Hospitals & Clinics

Ambulatory Surgical Centres

Long Term Care Centres

Others

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Chronic Idiopathic Constipation (CIC) Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Chronic Idiopathic Constipation (CIC) Drugs market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Chronic Idiopathic Constipation (CIC) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Chronic Idiopathic Constipation (CIC) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Chronic Idiopathic Constipation (CIC) Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Chronic Idiopathic Constipation (CIC) Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chronic Idiopathic Constipation (CIC) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Chronic Idiopathic Constipation (CIC) Drugs Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type

1.4.2 Lubiprostone

1.4.3 Linaclotide

1.4.4 Others

1.5 Market by Application

1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application

1.5.2 Hospitals & Clinics

1.5.3 Ambulatory Surgical Centres

1.5.4 Long Term Care Centres

1.5.5 Others

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size

2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2016-2025

2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2016-2025

2.2 Chronic Idiopathic Constipation (CIC) Drugs Growth Rate by Regions

2.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Regions

2.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers

3.1.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers

3.1.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers

3.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers

3.2.1 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2016-2018)

3.2.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2016-2018)

3.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturers

3.4 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Product Types

3.4.1 Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Category

3.4.3 Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type

4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type

4.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Breakdown Data by Application

6 North America

6.1 North America Chronic Idiopathic Constipation (CIC) Drugs by Countries

6.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries

6.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Chronic Idiopathic Constipation (CIC) Drugs by Type

6.3 North America Chronic Idiopathic Constipation (CIC) Drugs by Application

6.4 North America Chronic Idiopathic Constipation (CIC) Drugs by Company

7 Europe

7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs by Countries

7.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries

7.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs by Type

7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs by Application

7.4 Europe Chronic Idiopathic Constipation (CIC) Drugs by Company

8 Asia Pacific

8.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Countries

8.1.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries

8.1.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Type

8.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Application

8.4 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Company

9 Central & South America

9.1 Central & South America Chronic Idiopathic Constipation (CIC) Drugs by Countries

9.1.1 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries

9.1.2 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Chronic Idiopathic Constipation (CIC) Drugs by Type

9.3 Central & South America Chronic Idiopathic Constipation (CIC) Drugs by Application

9.4 Central & South America Chronic Idiopathic Constipation (CIC) Drugs by Company

10 Middle East and Africa

10.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Countries

10.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries

10.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Type

10.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Application

10.4 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Company

11 Company Profiles

11.1 Actavis

11.1.1 Actavis Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.1.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.1.5 Recent Development

11.2 Chugai Pharmaceutical

11.2.1 Chugai Pharmaceutical Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.2.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.2.5 Recent Development

11.3 Ferring International Center

11.3.1 Ferring International Center Company Details

11.3.2 Company Description

11.3.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.3.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.3.5 Recent Development

11.4 Synergy Pharmaceuticals

11.4.1 Synergy Pharmaceuticals Company Details

11.4.2 Company Description

11.4.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.4.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.4.5 Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Company Description

11.5.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.5.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.5.5 Recent Development

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 Company Description

11.6.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.6.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.6.5 Recent Development

11.7 Roche Holding

11.7.1 Roche Holding Company Details

11.7.2 Company Description

11.7.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.7.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.7.5 Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Company Description

11.8.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.8.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.8.5 Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Company Description

11.9.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.9.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.9.5 Recent Development

11.10 Salix Pharmaceuticals

11.10.1 Salix Pharmaceuticals Company Details

11.10.2 Company Description

11.10.3 Sales, Revenue and Gross Margin of Chronic Idiopathic Constipation (CIC) Drugs

11.10.4 Chronic Idiopathic Constipation (CIC) Drugs Product Description

11.10.5 Recent Development

11.11 Sucampo Pharmaceuticals

11.12 Ironwood Pharmaceuticals

11.13 Progenics Pharmaceuticals

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Chronic Idiopathic Constipation (CIC) Drugs Raw Material

13.1.2 Chronic Idiopathic Constipation (CIC) Drugs Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

List of Tables and Figures

Figure Picture of Chronic Idiopathic Constipation (CIC) Drugs

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Production Market Share by Types (Product Category) in 2017

Figure Lubiprostone Product Picture

Table Major Manufacturers of Lubiprostone

Figure Linaclotide Product Picture

Table Major Manufacturers of Linaclotide

Figure Others Product Picture

Table Major Manufacturers of Others

Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application 2018-2025 (K Units)

Figure Hospitals & Clinics

Figure Ambulatory Surgical Centres

Figure Long Term Care Centres

Figure Others

Figure Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market Size 2016-2025 (Million US$)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2016-2025 (K Units)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Regions 2016-2025 (K Units)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Regions 2016-2025

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Regions 2016-2025

Figure 2017 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Regions

Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Regions 2016-2025 (Million US$)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Regions 2016-2025

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Regions 2016-2025

Figure 2017 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Regions

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2016-2018) (K Units)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers (2016-2018)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers in 2017

Table Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2016-2018) (Million US$)

Table Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2016-2018)

Figure Chronic Idiopathic Constipation (CIC) Drugs Value Share by Manufacturers in 2017

Table Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Price (2016-2018) (USD/Unit)

Table Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Category

Table Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2016-2025)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type in 2017

Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2016-2025) (Million US$)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2016-2025)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2016-2025)

Figure Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type in 2017

Table Chronic Idiopathic Constipation (CIC) Drugs Price by Type 2013-2018 (USD/Unit)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2016-2025)

Figure Global Sales Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application (2016-2025)

Figure Global Sales Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application (2016-2025)

Figure North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2016-2025 (K Units)

Figure North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries (2016-2025) (K Units)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries

Table North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries (2016-2025) (Million US$)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries

Figure United States Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure United States Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure 2017 North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2016-2025)

Figure 2017 North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2016-2018) (K Units)

Table North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company (2016-2018)

Figure North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company in 2017

Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2016-2025 (K Units)

Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries (2016-2025) (K Units)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries (2016-2025) (Million US$)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries

Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (K Units)

Figure France Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure France Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (K Units)

Figure UK Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure UK Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2016-2018) (K Units)

Table Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company (2016-2018)

Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company in 2017

Figure Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2016-2025 (K Units)

Figure Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries (2016-2025) (K Units)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries (2016-2025) (Million US$)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries

Figure China Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure India Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure India Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Indonesia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Indonesia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Malaysia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Malaysia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Philippines Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Philippines Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Thailand Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Thailand Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Vietnam Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Vietnam Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Singapore Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Singapore Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2016-2018) (K Units)

Table Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company (2016-2018)

Figure Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company in 2017

Figure Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2016-2025 (K Units)

Figure Central & South America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries (2016-2025) (K Units)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries (2016-2025) (Million US$)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries

Figure Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2016-2018) (K Units)

Table Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company (2016-2018)

Figure Central & South America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company in 2017

Figure Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2016-2025 (K Units)

Figure Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Countries (2016-2025) (K Units)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Countries

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Countries (2016-2025) (Million US$)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Countries

Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2016-2025) (K Units)

Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2016-2025) (K Units)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2016-2025) (K Units)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2016-2018) (K Units)

Table Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company (2016-2018)

Figure Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Company in 2017

Table Actavis Company Details

Table Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Actavis Recent Development

Table Chugai Pharmaceutical Company Details

Table Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Chugai Pharmaceutical Recent Development

Table Ferring International Center Company Details

Table Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Ferring International Center Recent Development

Table Synergy Pharmaceuticals Company Details

Table Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Synergy Pharmaceuticals Recent Development

Table Pfizer Company Details

Table Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Pfizer Recent Development

Table GlaxoSmithKline Company Details

Table GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table GlaxoSmithKline Recent Development

Table Roche Holding Company Details

Table Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Roche Holding Recent Development

Table Sanofi Company Details

Table Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Sanofi Recent Development

Table Bayer Company Details

Table Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Bayer Recent Development

Table Salix Pharmaceuticals Company Details

Table Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Salix Pharmaceuticals Recent Development

Table Sucampo Pharmaceuticals Company Details

Table Ironwood Pharmaceuticals Company Details

Table Progenics Pharmaceuticals Company Details

Figure GDP by Regions / Largest Economies Pie Chart in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Table Chronic Idiopathic Constipation (CIC) Drugs Value Chain

Table Typical Suppliers of Key Chronic Idiopathic Constipation (CIC) Drugs Raw Material

Table Chronic Idiopathic Constipation (CIC) Drugs Customers List

Table Chronic Idiopathic Constipation (CIC) Drugs Sales Channels

Table Chronic Idiopathic Constipation (CIC) Drugs Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370